WEEKLY SUBCUTANEOUS ABATACEPT CONFERS COMPARABLE ONSET OF TREATMENT RESPONSE AND MAGNITUDE OF EFFICACY IMPROVEMENT OVER 6 MONTHS WHEN ADMINISTERED WITH OR WITHOUT AN INTRAVENOUS ABATACEPT LOADING DOSE Annual Meeting of the British-Society-for-Rheumatology and British-Health-Professionals-in-Rheumatology Schiff, M., Alten, R., Weinblatt, M. E., Nash, P., Fleischmann, R., Durez, P., Kaine, J., Delaet, I., Kelly, S., Maldonado, M., Patel, S., Genovese, M. OXFORD UNIV PRESS. 2013: 91–92

View details for Web of Science ID 000318569000256